Loading...

PE anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M170_PE_042706
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram) (gated on total cells).
  • M170_PE_042706
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE (filled histogram) or rat IgG2b, κ PE isotype control (open histogram) (gated on total cells).
  • M170_PE_CD11b_Antibody_IHC_031413
    Fixed whole mount mouse spleen was stained with Alexa Fluor® 488 F4/80 (red) (clone BM8), Brilliant Violet 421™ CD3ε (green) (clone 145-2C11), and PE CD11b (blue) (clone M1/70). Isotype controls at the same concentrations were used for the negative control. Cells were mounted in Prolong Gold and imaged with a Leica SP8 confocal. Image courtesy of Grzegorz Chodaczek and Zbigniew Mikulski at LIAI.
Compare all formats See PE spectral data See more IHC data...
Cat # Size Price Quantity Check Availability Save
101207 50 µg £39
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101208 200 µg £119
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/mL
Storage & Handling
The CD11b antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
IHC - Verified
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  2. Chida J, et al. 2020. PLoS Pathog. 16:e1008823. PubMed
  3. Guo Y, et al. 2021. Exp Ther Med. 353:21. PubMed
  4. Ho YH, et al. 2019. Cell Stem Cell. 25:407. PubMed
  5. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  6. Kisielow J, et al. 2019. Nat Immunol. 1.286111111. PubMed
  7. Li A, et al. 2020. Oncol Lett. 1.899305556. PubMed
  8. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  9. Kuo PC, et al. 2021. Brain Commun. 3:fcab187. PubMed
  10. Zhao D, et al. 2021. Innate Immun. 27:533. PubMed
  11. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  12. Nigam S, et al. 2020. Mol Imaging Biol. 22:685. PubMed
  13. Yates AG, et al. 2021. J Neuroinflammation. 18:15. PubMed
  14. Witherel CE, et al. 2021. Biomaterials. 269:120667. PubMed
  15. DeBuque RJ, et al. 2022. Dev Dyn. 251:988. PubMed
  16. He D, et al. 2022. Immunity. 55:159. PubMed
  17. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  18. Shang SQ, et al. 2022. Neoplasma. 69:755. PubMed
  19. Tan YY, et al. 2022. Bio Protoc. 12:e4307. PubMed
  20. Wemlinger SM, et al. 2022. J Immunol. 208:1566. PubMed
  21. Li Y, et al. 2022. J Exp Clin Cancer Res. 41:128. PubMed
  22. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  23. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  24. Qin L, et al. 2022. Sci Adv. 8:eabn3774. PubMed
  25. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  26. Albayrak E, et al. 2022. J Cell Biochem. 123:2009. PubMed
  27. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  28. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  29. McNamara NB, et al. 2023. Nature. 613:120. PubMed
  30. Sundarasivarao PYK, et al. 2022. Front Immunol. 13:1011944. PubMed
  31. Morrow RJ, et al. 2022. Cells. 11: . PubMed
  32. Ullah I, et al. 2023. Cell Rep Med. 4:100893. PubMed
  33. Pavliuchenko N, et al. 2023. Front Immunol. 13:1035226. PubMed
  34. Marritt KL, et al. 2023. Front Immunol. 13:1087991. PubMed
  35. Tanaka T, et al. 2023. Nat Immunol. 24:439. PubMed
  36. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  37. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  38. Citro A, et al. 2023. Nat Commun. 14:878. PubMed
  39. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  40. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  41. Marsh SE, et al. 2022. Nat Neurosci. 25:306. PubMed
  42. Ajay AK, et al. 2022. Cell Rep. 38:110473. PubMed
  43. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  44. Ramdas B, et al. 2022. Mol Ther. 30:2505. PubMed
  45. Hu K, et al. 2022. J Extracell Vesicles. 11:e12199. PubMed
  46. Li T, et al. 2022. J Leukoc Biol. 112:845. PubMed
  47. Sauter M, et al. 2022. STAR Protoc. 3:101664. PubMed
  48. Glorieux C, et al. 2022. J Adv Res. 40:109. PubMed
  49. Krasniewski LK, et al. 2022. Elife. 11:. PubMed
  50. Wu Q, et al. 2023. Front Immunol. 13:1081719. PubMed
  51. Suzuki Y, et al. 2023. Front Immunol. 14:1089905. PubMed
  52. Zhang L, et al. 2023. Commun Biol. 6:211. PubMed
  53. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  54. Sang H, et al. 2023. Adv Clin Exp Med. 32:551. PubMed
  55. Ma X, et al. 2023. Nat Commun. 14:1606. PubMed
  56. Mascarau R, et al. 2023. J Cell Biol. 222:. PubMed
  57. Okano F, et al. 2023. Cancer Res Commun. 3:640. PubMed
  58. He Q, et al. 2023. Parasit Vectors. 16:139. PubMed
  59. Petenkova A, et al. 2023. Nat Commun. 14:2761. PubMed
  60. Xu J, et al. 2023. Discov Oncol. 14:68. PubMed
  61. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  62. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  63. Zhao C, et al. 2023. NPJ Regen Med. 8:29. PubMed
  64. Lei G, et al. 2016. Antimicrob Agents Chemother. 60: 1289 - 1297. PubMed
  65. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  66. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  67. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  68. Bhatt K, et al. 2018. mSphere. 3:e00352. PubMed
  69. Baryawno N et al. 2019. Cell. 177(7):1915-1932 . PubMed
  70. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  71. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  72. Prajeeth C,et al. 2017. J Neuroinflammation.. 10.1186/s12974-017-0978-3. PubMed
  73. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  74. Yan F, et al. 2022. Cancer Discov. 12:792. PubMed
  75. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  76. Zhao X, et al. 2022. Front Mol Biosci. 9:786864. PubMed
  77. Deng Y, et al. 2021. Acta Pharmacol Sin. 42:149. PubMed
  78. Pan J, et al. 2021. Mol Ther Nucleic Acids. 26:970. PubMed
  79. Li X, et al. 2015. Proc Natl Acad Sci U S A. 112:6080. PubMed
  80. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  81. Dumas SJ, et al. 2021. STAR Protocols. 2(3):100523. PubMed
  82. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  83. Gonçalves NP, et al. 2017. J Neuroinflammation. 14:115. PubMed
  84. Yamauchi T et al. 2018. Cancer cell. 33(3):386-400 . PubMed
  85. Xiao X, et al. 2020. J Hematol Oncol. 0.597222222. PubMed
  86. Elkabets M, et al. 2009. J Immunol. 182:4874. PubMed
  87. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  88. Conforti A, et al. 2021. PLoS One. 16:e0259894. PubMed
  89. Götz P, et al. 2022. Int J Mol Sci. 23:. PubMed
  90. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  91. Forte E, et al. 2020. J Cell Mol Med. . PubMed
  92. Earnest JT, et al. 2021. Cell Reports. 35(1):108962. PubMed
  93. Jard T, et al. 2020. Cell Stem Cell. 27(4):646-662.e7. PubMed
  94. Forte D, et al. 2020. Cell Metab. 32:829. PubMed
  95. Coppo M, et al. 2016. Nat Commun. 7:12254. PubMed
  96. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  97. Hiraishi Y, et al. 2018. Sci Rep. 8:18052. PubMed
  98. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  99. Llewellyn GN, et al. 2018. J Neurovirol. 24:192. PubMed
  100. Sun Y et al. 2018. Cancer cell. 34(4):643-658 . PubMed
  101. Shears RK, et al. 2020. J Allergy Clin Immunol. 145:1272. PubMed
  102. Chen X, et al. 2021. Cell Death Differ. 28:1237. PubMed
  103. Stolp B, et al. 2022. Cell Rep. 38:110387. PubMed
  104. Craver BM, et al. 2020. Blood Adv. 4:312. PubMed
  105. Price J, et al. 2015. Diabetes. 64: 3521 - 3531. PubMed
  106. Kalucka J, et al. 2020. Cell. 764:180. PubMed
  107. Turkowski K, et al. 2017. Glia. 10.1002/glia.23234. PubMed
  108. Wiese A, et al. 2017. PLoS One. 10.1371/journal.pone.0184956. PubMed
  109. Hengyou Weng et al. 2018. Cell stem cell. 22(2):191-205 . PubMed
  110. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  111. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  112. Ganeshan K et al. 2019. Cell. 177(2):399-413 . PubMed
  113. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  114. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  115. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  116. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  117. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  118. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  119. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  120. Chen F, et al. 2022. Evid Based Complement Alternat Med. 2022:1240242. PubMed
  121. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  122. Haugh KA, et al. 2021. eLife. 0.416666666666667. PubMed
  123. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  124. Endo Y, et al. 2020. FASEB J. 34:16086. PubMed
  125. Diao N, et al. 2016. Sci Rep. 6:34672. PubMed
  126. Huang L, et al. 2016. J Biol Chem. 291: 6232 - 6244. PubMed
  127. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  128. Pan J, et al. 2020. J Neuroinflammation. 17:97. PubMed
  129. Paraiso HC, et al. 2018. J Neuroinflammation. 0.694444444. PubMed
  130. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  131. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  132. Hammond TR, et al. 2019. Immunity. 50:253. PubMed
  133. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  134. Li K, et al. 2022. J Immunother Cancer. 10:. PubMed
  135. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  136. Rogawski DS, et al. 2021. Nat Commun. 12:2792. PubMed
  137. Trenevska I, et al. 2021. PLoS One. 16:e0249967. PubMed
  138. Gordon RA, et al. 2020. PLoS One. 15:e0226396. PubMed
  139. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  140. Xiao Z, et al. 2015. Cancer Lett. 360:302. PubMed
  141. Donley DW, et al. 2021. PLOS ONE. 16(5):e0250606. PubMed
  142. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  143. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  144. An J,et al. 2017. Sci Rep.. 10.1038/s41598-017-13629-0. PubMed
  145. Wang L, et al. 2017. Front Immunol.. 10.3389/fimmu.2017.01754. PubMed
  146. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  147. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  148. Zhang S, et al. 2019. Mol Med Rep. 19:5377. PubMed
  149. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  150. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  151. Nakaya M, et al. 2017. J Clin Invest. 127:383. PubMed
  152. Mayo L, et al. 2008. J Immunol. 181:92. PubMed
  153. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  154. Zheng Y, et al. 2022. Front Pharmacol. 12:816032. PubMed
  155. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  156. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  157. Zhang X, et al. 2022. Cells. 11:. PubMed
  158. Jin R, et al. 2020. Mol Cancer Ther. . PubMed
  159. Nguyen TKT, et al. 2020. Am J Pathol. 286:190. PubMed
  160. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  161. Pang D, et al. 2015. Clin Transl Immunology. 4: e41. PubMed
  162. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  163. Keshavarz M, et al. 2020. Virol J. 17:64. PubMed
  164. He L, et al. 2019. iScience. 0.790972222. PubMed
  165. Frazier T, et al. 2018. Adipocyte. 0.41875. PubMed
  166. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  167. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  168. Anstine L,et al. 2017. J Am Heart Assoc.. 10.1161/JAHA.117.007097. PubMed
  169. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  170. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  171. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  172. Jaworska K, et al. 2015. J Immunol. 194:325. PubMed
  173. Chen Y, et al. 2015. PLoS One. 10: 0135217. PubMed
  174. Li L, et al. 2015. J Am Soc Nephrol. 26: 2183-2197. PubMed
  175. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  176. Hönes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  177. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  178. Hou M, et al. 2020. Stem Cell Res Ther. 11:55. PubMed
  179. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  180. Hildebrand KM, et al. 2021. PLoS One. 16:e0253864. PubMed
  181. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  182. Malekghasemi S, et al. 2020. Cell Biol Int. 44:2031. PubMed
  183. Han D, et al. 2021. J Immunol Res. 6688053:2021. PubMed
  184. Nguyen GT, et al. 2021. iScience. 24(8):102871. PubMed
  185. Garg M, et al. 2021. Cell Reports. 34(6):108736. PubMed
  186. Cao DY, et al. 2020. J Biol Chem. 295:1369. PubMed
  187. Moorlag SJCFM, et al. 2020. Cell Rep. 33:108387. PubMed
  188. Koshida R, et al. 2015. Biochem Biophys Res Commun. 463: 109-115. PubMed
  189. Textor A, et al. 2014. Cancer Res. 74:6769. PubMed
  190. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  191. Luong-Gardiol N, et al. 2019. Cancer Cell. 35:649. PubMed
  192. Murray C, et al. 2018. Lab Chip. 18:2396. PubMed
  193. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  194. Baik JE, et al. 2022. Clin Transl Med. 12:e758. PubMed
  195. Di Martino L, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:901. PubMed
  196. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  197. Lin S, et al. 2022. Nat Commun. 13:3301. PubMed
  198. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  199. Kan X, et al. 2015. Cardiovasc Res. 10.1093/cvr/cvv255. PubMed
  200. Mizuno T, et al. 2017. Sci Rep. 7:42714. PubMed
  201. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  202. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  203. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  204. He J, et al. 2019. J Clin Invest. 130. PubMed
  205. Huang Y, et al. 2019. Cancer Cell. 35:677. PubMed
  206. Ruiz de Azua I, et al. 2017. J Clin Invest. 127:4148. PubMed
  207. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  208. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  209. Haas MS, et al. 2020. Mol Cancer Res. 19:717. PubMed
  210. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  211. Yang Y, et al. 2022. Elife. 11:. PubMed
  212. Bolkhovitina EL, et al. 2022. Int J Mol Sci. 23: . PubMed
  213. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  214. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  215. Sokol L, et al. 2021. STAR Protocols. 2(2):100489. PubMed
  216. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  217. Troutman TD, et al. 2021. STAR Protocols. 2(1):100363. PubMed
  218. Wang L, et al. 2012. PLoS One. 7:e40056. PubMed
  219. Staschke K, et al. 2009. J Immunol. 183:568. PubMed
  220. Challa TD, et al. 2020. Cell Reports. 30(10):3424-3433. PubMed
  221. Minuesa G, et al. 2019. Nat Commun. 10:2691. PubMed
  222. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  223. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  224. Wang Q, et al. 2018. Int J Biol Sci. 14:147. PubMed
  225. Perez-Garcia CG, et al. 2022. Mol Ther Nucleic Acids. 28:87. PubMed
  226. Uslu M, et al. 2020. J Cell Physiol. 235:9644. PubMed
  227. Zhai K, et al. 2021. Nat Cancer. 2:1136. PubMed
  228. Chiang HY, et al. 2022. Nat Commun. 13:874. PubMed
  229. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  230. Bermejo-Jambrina M, et al. 2021. EMBO J. 40:e106765. PubMed
  231. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  232. Langhauser F, et al. 2014. Stroke. 45:1799. PubMed
  233. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  234. Favuzzi E, et al. 2021. Cell. 184(15):4048-4063.e32. PubMed
  235. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  236. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  237. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  238. Gomez–Ospina N, et al. 2019. Nat Commun. 3.225694444. PubMed
  239. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  240. Tan S, et al. 2006. J Immunol. 176:2872. PubMed
  241. Roy AG, et al. 2021. Int J Mol Sci. 22:. PubMed
  242. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  243. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  244. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  245. Nuro-Gyina PK, et al. 2021. J Immunol. 207:868. PubMed
  246. Babagana M, et al. 2021. Aging (Albany NY). 13:19207. PubMed
  247. Li Q, et al. 2022. Front Cardiovasc Med. 9:872102. PubMed
  248. Dungan CM, et al. 2022. Aging Cell. 21:e13528. PubMed
  249. Li T, et al. 2021. J Neuroinflammation. 81:18. PubMed
  250. Guo M, et al. 2020. Brain. 1476:143. PubMed
  251. Houben T, et al. 2020. J Pathol. 251:429. PubMed
  252. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  253. Li L, et al. 2014. J Immunol. 192:1034. PubMed
  254. Demers M, et al. 2012. Proc Natl Acad Sci U S A. 109:13076. PubMed
  255. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  256. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  257. Li YT, et al. 2019. Elife. 8:e47642. PubMed
  258. Luck H, et al. 2019. Nat Commun. 10:3650. PubMed
  259. Xiao G, et al. 2018. Cell. 173:470. PubMed
  260. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  261. Wu ZJ, et al. 2018. Int J Oncol. 52:1209. PubMed
  262. Szeifert V, et al. 2021. Front Immunol. 12:671995. PubMed
  263. Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed
  264. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  265. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  266. Cao W, et al. 2021. Int J Mol Sci. 22:. PubMed
  267. Calle P, et al. 2021. Cells. 10:. PubMed
  268. Ding H, et al. 2016. Nat Commun. 7:11533. PubMed
  269. Yuan Y, et al. 2020. Front Physiol. 0.967361111. PubMed
  270. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  271. Toyohara T, et al. 2020. Cell Stem Cell. 27:147. PubMed
  272. Bennett FC, et al. 2018. Neuron. 98:1170. PubMed
  273. Zhang T, et al. 2018. PLoS One. 13:e0196571. PubMed
  274. Eisemann T, et al. 2019. Front Oncol. 9:187. PubMed
  275. Cá B, et al. 2019. Front Microbiol. 1.876388889. PubMed
  276. Dong Y, et al. 2021. Commun Biol. 4:560. PubMed
  277. Scheiblich H, et al. 2021. Cell. 184:5089. PubMed
  278. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  279. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  280. Lin KH, et al. 2020. Nat Genet. 52:408. PubMed
  281. Jablonski K, et al. 2015. PLoS One. 10: 0145342. PubMed
  282. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  283. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  284. Resende M, et al. 2013. J Immunol. 191:262. PubMed
  285. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
  286. Liu Y, et al. 2019. Sci Rep. 9:18970. PubMed
  287. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  288. Gerdes P, et al. 2022. Nat Commun. 13:7470. PubMed
  289. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  290. Wang X, et al. 2021. Cell. 184:5357. PubMed
  291. Li Y, et al. 2020. Theranostics. 10:2897. PubMed
  292. Xia D, et al. 2022. Mol Neurodegener. 17:41. PubMed
  293. Koide S, et al. 2022. iScience. 25:103603. PubMed
  294. Lin T, et al. 2021. PLoS Pathog. 17:e1009557. PubMed
  295. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  296. Kuo P, et al. 2016. J Am Heart Assoc. 5: 002610. PubMed
  297. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  298. Avalle L, et al. 2020. Mol Ther Methods Clin Dev. 0.793055556. PubMed
  299. Zhou Q, et al. 2020. Nat Immunol. 1.393055556. PubMed
  300. Wang Z et al. 2019. Cell reports. 26(5):1273-1285 . PubMed
  301. Schaftenaar FH, et al. 2019. Sci Rep. 9:17391. PubMed
  302. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  303. Nguyen GT, et al. 2020. eLife. 9:e56656.. PubMed
  304. Hoyer FF, et al. 2020. Immunity. 51(5):899-914.e7.. PubMed
  305. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  306. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  307. Zhang A, et al. 2021. Theranostics. 11:3839. PubMed
  308. Zhai T, et al. 2020. Clin Exp Pharmacol Physiol. 47:677. PubMed
  309. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  310. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  311. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  312. Baruch K, et al. 2015. EMBO J. 34: 1816 - 1828. PubMed
  313. Schmidt C, et al. 2005. J Immunol. 175:2286. PubMed
  314. Danne C et al. 2017. Cell host & microbe. 22(6):733-745 . PubMed
  315. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  316. Bozoglu T, et al. 2022. Adv Sci (Weinh). 9:e2103867. PubMed
  317. Shen H, et al. 2022. Nat Commun. 13:5013. PubMed
  318. Zhang X, et al. 2022. J Exp Clin Cancer Res. 41:246. PubMed
  319. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  320. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  321. Bahmani B, et al. 2021. Nat Commun. 12:1999. PubMed
  322. Fielding C, et al. 2022. Nat Commun. 13:543. PubMed
  323. Hirako N, et al. 2014. PLoS One. 9:103282. PubMed
  324. Chen Z, et al. 2016. Innate Immunity. 22: 419 - 432. PubMed
  325. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  326. Evavold CL, et al. 2021. Cell. 184(17):4495-4511.e19. PubMed
  327. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  328. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  329. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  330. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  331. Zhang M, et al. 2019. Autophagy. 1.423611111. PubMed
  332. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  333. Henkle TR, et al. 2021. Cancer Res. 81:4560. PubMed
  334. Gawish R, et al. 2022. Elife. 11:. PubMed
  335. Wang T, et al. 2022. Int J Nanomedicine. 17:2191. PubMed
  336. Nabekura T, et al. 2020. Immunity. 96:52. PubMed
  337. Wong PP, et al. 2020. Cell. 181(6):1346-1363.e21. PubMed
  338. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  339. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  340. K K, et al. 2016. Haematologica. 151159. PubMed
  341. Han J, et al. 2015. Cancer Res . 75: 5273 - 5282. PubMed
  342. Cai W, et al. 2019. J Neuroinflammation. 0.788194444. PubMed
  343. Fernando N, et al. 2020. Front Cell Dev Biol. 0.691666667. PubMed
  344. Dougan M, et al. 2018. Cancer Immunol Res. 6:389. PubMed
  345. Abdel Malik R, et al. 2017. Circ Res. 120:99. PubMed
  346. Saber M, et al. 2021. J Neurotrauma. 38:2862. PubMed
  347. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  348. Zhang SJ, et al. 2021. Adv Sci (Weinh). 8:2003410. PubMed
  349. Steinmetz TD, et al. 2021. Autophagy. 17:2238. PubMed
  350. Hohsfield LA, et al. 2021. Elife. 10:. PubMed
  351. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  352. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  353. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  354. Rana MN, et al. 2021. Front Pharmacol. 12:643215. PubMed
RRID
AB_312790 (BioLegend Cat. No. 101207)
AB_312790 (BioLegend Cat. No. 101208)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Go To Top Version: 2    Revision Date: 03/14/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account